Midgard Science

2bind Pharma Services

Regensburg, Germany 2bind.com

From their website, Nov 2026

Work here? Claim this listing

About

2bind Pharma Services is a contract research organization supporting small molecule drug discovery and antibody development for biotech and pharma clients. It provides integrated and stand-alone preclinical R&D services from protein purification and screening through lead optimization, developability, preformulation, and formulation development. The company is based in Germany and works with therapeutic small molecules, antibodies, and other biologics.

Services

  • Protein target purification

    Construct design consulting, production consulting, purification monitoring, and quality controlling for small molecule discovery workflows.

    Protein production

  • Hit identification

    Assay establishment, assay upscaling, and screening for binding and function to find initial hits.

    Assays & in vitro testing

  • Hit validation

    Orthogonal assay suites for functional and binding validation of screened hits.

    Assays & in vitro testing

  • Hit-to-lead optimization

    Binding assays for clustering, support for SAR efforts, rapid assay turnover, and upscaling for lead optimization.

    Assays & in vitro testing

  • Lead optimization

    Support for medchem campaigns, rapid assay turnover, in-depth characterization, and IND filing support.

    Assays & in vitro testing

  • Small-scale antibody production

    Cloning and expression, purification, and QC with a stated 15-25 days turnaround time.

    Protein production

  • Antibody screening

    High-throughput binding screens with purified target protein and target cells, developability screens, and affinity ranking.

    Assays & in vitro testing

  • Lead selection

    Comprehensive kinetics on purified protein and target cells, EC50 determination, real-time kinetics on cells, advanced developability studies, off-target screens, and cell-based functional assays.

    Assays & in vitro testing

  • Lead candidate risk assessment and mitigation

    Preformulation studies, storage stability studies, accelerated stability, and viscosity determination for 1-2 molecules.

    Minimum 1-2 molecules · Assays & in vitro testing

  • Preclinical liquid formulation development

    Liquid formulation development, high-concentration formulation development, and small-scale manual filling for preclinical downstream tests.

    Minimum 1-2 molecules

  • Small molecule direct binding assays

    Affinity, kinetics, covalent binding, stoichiometry, interaction thermodynamics, thermal shift, screening of small sets or libraries, and ternary complex assay formats using methods such as SPR, GCI, ITC, MST, FP, BLI, nanoDSF, DLS, and flow cytometry.

    Assays & in vitro testing

  • Small molecule functional assays

    Cell viability and toxicity, cellular signaling and response, target engagement, and enzyme kinetics assays.

    Assays & in vitro testing

  • Small molecule physicochemical and stability assessments

    Aggregation and solubility, conformational and colloidal stability, target size and oligomerization, and target aggregator assays for binding analysis and stability optimization.

    Assays & in vitro testing

  • Antibody target binding assays

    Binding screens, affinity ranking and avidity, and kinetics of target and target cell binding using platforms including SPR, GCI, BLI, ELISA, heliXcyto, scIC, KinExA, RT-IC, and flow cytometry.

    Assays & in vitro testing

  • Antibody functional characterization

    Ligand inhibition, NK/T-cell recruiting assay, signal induction, cell killing, and internalization studies.

    Assays & in vitro testing

  • Antibody physicochemical and stability assessments

    Multiparametric unfolding and aggregation studies, conformational and colloidal stability, self-interaction assessment, size and LMW/HMW content determination, and hydrophobicity and charge heterogeneity profiling.

    Assays & in vitro testing

  • Direct binding assays

    Measures affinity, kinetics, covalent binding, stoichiometry, interaction thermodynamics, and ternary complex formation using biophysical platforms.

    Assays & in vitro testing

  • Functional assays

    Runs cell viability, cellular signaling, target engagement, and enzyme kinetics assays using BSL1/BSL2 systems and state-of-the-art kits.

    Assays & in vitro testing

  • Physicochemical and stability assessments

    Assesses aggregation, solubility, conformational stability, oligomerization, and lead stability optimization for small molecules.

    Assays & in vitro testing

  • Hit-to-lead

    Supports binding assays for clustering, SAR efforts, rapid assay turnover, and lead optimization.

    Assays & in vitro testing

  • Small scale protein target purification

    Offers construct design consulting or access to catalogue proteins, production consulting, purification monitoring, and quality controlling as a stand-alone small molecule service.

    Protein production

  • Target feasibility platform

    Checks whether a target construct is suitable for a relevant binding assay within two weeks.

    Assays & in vitro testing

  • Binding screens with purified protein and cells

    Screens antibodies against purified target protein and target cells using SPR, GCI, BLI, ELISA, heliXcyto, scIC, flow cytometry, and KinExA.

    Assays & in vitro testing

  • Affinity ranking & avidity

    Ranks binding affinity and avidity for antibodies using protein- and cell-based methods.

    Assays & in vitro testing

  • Kinetics of target and target cell binding

    Measures antibody binding kinetics on purified targets and cells.

    Assays & in vitro testing

  • Functional characterization

    Evaluates antibody ligand inhibition, NK/T-cell recruiting activity, signal induction, cell killing, and internalization.

    Assays & in vitro testing

  • Receptor quantification assay

    Quantifies receptors using flow cytometry in BSL1 or BSL2 settings.

    Assays & in vitro testing

  • Storage stability assessment

    Runs accelerated, stress, thermal, colloidal, mechanical, oxidative, and chemical stability studies for antibodies.

    Assays & in vitro testing

  • Stability optimization via Design of Experiment

    Uses pre-formulation, DSD, RSM, and DoE approaches to optimize antibody stability.

    Assays & in vitro testing

  • Target protein deconvolution

    Supports target protein deconvolution with protein array-based approaches.

    Assays & in vitro testing

Lead time
15-25 days turnaround time · Within two weeks
What to send
20 µg per molecule · 500 µg per molecule · 100s of molecules (20 µg per molecule) · 10s of molecules (500 µg per molecule) · 1-2 molecules

Capabilities

As they state on their website or in their listing.

Processes
Small molecule · Antibody · Oligonucleotide · Small molecules · Antibodies · SPR · BLI · Stability studies · Flow cytometry · HPLC · ELISA
Capacity
100s of molecules · 10s of molecules · 1-2 molecules · 20 µg per molecule · 500 µg per molecule · 15-25 days turnaround time · 100s of molecules (20 µg per molecule) · 10s of molecules (500 µg per molecule)
Scales
Gram
Data supplied
HPLC

Equipment

  • SPR
  • GCI
  • BLI
  • ITC
  • MST
  • FP
  • Flow Cytometry
  • nanoDSF
  • DLS
  • SEC-MALS
  • HPLC
  • UPLC
  • CE-SDS
  • ELISA
  • KinExA
  • FP assay
  • heliXcyto
  • scIC
  • NanoBRET®
  • TRIC

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO 9001Self-reported

    As listed: ISO 9001 certified quality management sy (All services)

  • GMPSelf-reported

Industries served

  • Biopharma
  • Biotech
  • Pharma

Company

Type
CRO

Locations

Based in
Regensburg, Germany
Sites
Germany, Germany

Contacts

Similar labs

Work here? Claim this listing